Filing Analysis
Officer Departure
Filed Mar 27, 2026
LOW
Rapid Micro Biosystems, Inc. announced the departure of Chief Operating Officer John Wilson, effective April 10, 2026. CEO Robert Spignesi will assume the role of principal operating officer, and Mr. Wilson will provide consulting services through June 30, 2026.
Key Facts
- John Wilson notified the company of his departure on March 23, 2026, citing a desire to spend more time with family.
- The departure is not the result of any disagreement with the company regarding operations, policies, or practices.
- CEO Robert Spignesi will take over the responsibilities of principal operating officer effective April 10, 2026.
- Mr. Wilson entered into a Consulting Services and Separation Agreement on March 26, 2026.
- The consulting agreement pays $200 per hour, capped at 20 hours per month, ending June 30, 2026.
- Mr. Wilson's vested stock options exercise period is extended to March 31, 2027, subject to weekly volume selling limits.
Regulation FD Disclosure
Filed Mar 12, 2026
LOW
Rapid Micro Biosystems reported its Q4 and full-year 2025 financial results and announced a significant multi-system order from Samsung Biologics for its Growth Direct platform.
Key Facts
- Announced financial results for the fourth quarter and fiscal year ended December 31, 2025, on March 12, 2026.
- Disclosed a new multi-system order from Samsung Biologics for the Company's Growth Direct platform.
- The filing includes Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD Disclosure).
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.